European Biotechnology: Summer edition 2019

Berlin, 12.06.2019 – Drug safety is the focus of the latest issue of European Biotechnology. The title story describes how novel biomarkers have been validated to detect drug-induced organ injuries.

In einem Interview erläutert der CEO des polnischen Biotech-Unternehmens Selvita Pawel Przewiezlikowski die Gründe für die jüngste Aufteilung seines Unternehmens in einen Medikamentenentwickler und ein CRO. Weitere Top-Stories sind das umfangreiche Impfprogramm gegen Malaria, das Versprechen einer zellfreien Produktion im Biomanufacturing und die Debatte um die Genombearbeitung der Keimbahn.

On the regional pages, the magazine contains news from Northern, Southern, Western, Eastern and Central Europe. Readers can read up on current clinical studies and find worthwhile life sciences events in the second half of 2019 in the Biofairs Compass.

Browse online: european-biotechnology.com

Get a free sample copy: european-biotechnology.com

What can we do for you?

Are you interested in our products or services? Please do not hesitate to contact us. We will be pleased to provide you with a quote – flexible and tailored directly to your needs. You can also call us at +49 (0)30 2649210.